Pharmacovigilance and Pharmacists’ Role
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (30 April 2025) | Viewed by 1615
Special Issue Editor
Interests: psychiatric diseases; adherence; pharmacy practice research
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As healthcare professionals who are not only most accessible to patients but also have direct access to information on patients’ drugs and supplement utilization, pharmacists are uniquely positioned to contribute significantly to the safe use of drugs. This Special Issue seeks to gather research highlighting how pharmacists can enhance drug safety monitoring, reporting of adverse drug reactions, and overall medication management. Topics may include, but are not limited to, the pharmacists’ role in detecting drug safety issues in daily clinical practice, the impact of pharmacist-led interventions on adverse drug reaction reporting rates, and the development of educational programs to enhance pharmacists’ competencies in pharmacovigilance. The aim is to advance understanding of how pharmacists can effectively contribute to safer medication use and improve patient outcomes through proactive monitoring and reporting.
Dr. Josipa Bukić
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug safety
- pharmacists
- adverse drug reaction
- pharmacovigilance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
